Published in Neurology on June 01, 1997
Motor neurone disease. Postgrad Med J (2002) 1.06
Amyotrophic lateral sclerosis-motor neuron disease, monoclonal gammopathy, hyperparathyroidism, and B12 deficiency: case report and review of the literature. J Med Case Rep (2010) 0.98
Retroviruses and amyotrophic lateral sclerosis. Antiviral Res (2013) 0.94
Amyotrophic lateral sclerosis with laboratory abnormalities of uncertain significance: A brief review. Iran J Neurol (2012) 0.80
Association of IgM monoclonal gammopathy with progressive muscular atrophy and multifocal motor neuropathy: a case-control study. J Neurol (2015) 0.76
An Autopsy Case of Amyotrophic Lateral Sclerosis with Waldenström Macroglobulinemia and Anti-MAG Gammopathy. Case Rep Neurol (2011) 0.75
Absence of paraneoplastic antineuronal antibodies in sera of 145 patients with motor neuron disease. J Neurol Neurosurg Psychiatry (2007) 0.75
Lymphoproliferative disorders and motor neuron disease. Neurology (1998) 0.75
Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol (1984) 5.21
Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology (1988) 4.28
Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell (1988) 3.57
Wish to die in end-stage ALS. Neurology (2005) 2.97
Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell (1988) 2.94
Prevalence of essential tremor: door-to-door neurologic exams in Mersin Province, Turkey. Neurology (2003) 2.88
Inclusion body myositis and myopathies. Ann Neurol (1995) 2.68
IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block. Ann Neurol (1990) 2.67
Primary lateral sclerosis. A clinical diagnosis reemerges. Arch Neurol (1988) 2.62
Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology (2009) 2.60
Electrophysiological findings in entrapment of the median nerve at wrist and elbow. J Neurol Neurosurg Psychiatry (1974) 2.54
Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol (2001) 2.54
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology (2007) 2.41
The natural history of primary lateral sclerosis. Neurology (2006) 2.31
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology (2006) 2.25
Premorbid weight, body mass, and varsity athletics in ALS. Neurology (2002) 2.23
Ring finger testing in carpal tunnel syndrome: a comparative study of diagnostic utility. Muscle Nerve (1989) 2.21
Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2005) 2.16
Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord (1992) 2.15
Accuracy of family history data on Parkinson's disease. Neurology (2003) 2.15
Neurolymphomatosis: a clinicopathologic syndrome re-emerges. Neurology (1992) 2.14
The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology (2003) 2.11
Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology (2004) 2.09
The association of incident dementia with mortality in PD. Neurology (2002) 2.07
Distant effects of local injection of botulinum toxin. Muscle Nerve (1987) 2.02
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology (1994) 2.00
Complications of intravenous immune globulin treatment in neurologic disease. Neurology (1996) 1.97
Myoglobinuria. Med Clin North Am (1972) 1.95
Multifocal motor neuropathy with conduction block: is it a distinct clinical entity? Neurology (1992) 1.93
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord (1987) 1.92
Lumping or splitting? "Ophthalmoplegia-plus" or Kearns-Sayre syndrome? Ann Neurol (1977) 1.90
The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology (1990) 1.87
Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol (2000) 1.82
Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry (2000) 1.82
Personality in essential tremor: further evidence of non-motor manifestations of the disease. J Neurol Neurosurg Psychiatry (2004) 1.82
Benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase deficiency. Ann Neurol (1983) 1.82
Prevalence of depressive disorders and change over time in late-stage ALS. Neurology (2005) 1.80
Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Muscle Nerve (1991) 1.77
Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups. Neurology (1996) 1.77
Respiratory distress as the initial manifestation of Werdnig-Hoffmann disease. Pediatrics (1974) 1.76
Peripheral neuropathy in patients with inflammatory bowel disease. Brain (2005) 1.75
Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy. J Neurochem (1982) 1.75
Risk of incident Parkinson's disease and parkinsonism in essential tremor: a population based study. J Neurol Neurosurg Psychiatry (2009) 1.74
Riluzole for the treatment of amyotrophic lateral sclerosis--too soon to tell? N Engl J Med (1994) 1.73
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Adv Neurol (1988) 1.72
A prospective study of preferences and actual treatment choices in ALS. Neurology (1999) 1.71
Diabetic peripheral neuropathy: a clinicopathologic and immunohistochemical analysis of sural nerve biopsies. Muscle Nerve (1996) 1.69
Cramps. N Engl J Med (1971) 1.67
"Maximal" thymectomy for myasthenia gravis. Results. J Thorac Cardiovasc Surg (1988) 1.63
Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology (2007) 1.63
Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes. Neurology (1990) 1.61
Muscular dystrophy in young girls. Neurology (1970) 1.60
Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis. Ann Neurol (1991) 1.60
Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology (1992) 1.58
Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain. Neurology (2004) 1.57
Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol (2001) 1.55
Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial. Arch Ophthalmol (1996) 1.55
Muscle phosphofructokinase deficiency. Arch Neurol (1967) 1.54
Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin. N Engl J Med (1980) 1.54
Outcome of selective ramisectomy for botulinum toxin resistant torticollis. J Neurol Neurosurg Psychiatry (1998) 1.52
Polyglucosan body disease. Muscle Nerve (1991) 1.50